Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SHR-1703 / Jiangsu Hengrui Pharma
NCT05979051: A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）	Recruiting	2/3	112	RoW	SHR-1703, SHR-1703 Placebo	Guangdong Hengrui Pharmaceutical Co., Ltd	Eosinophilic Granulomatosis With Polyangiitis	03/26	05/27
NCT05522439: A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype	Active, not recruiting	2	85	RoW	SHR-1703, SHR-1703 Placebo	Jiangsu HengRui Medicine Co., Ltd.	Asthma With Eosinophilic Phenotype	12/23	06/24
SHR-1703-202, NCT06441812: A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients	Not yet recruiting	2	200	NA	SHR-1703 Injection	Guangdong Hengrui Pharmaceutical Co., Ltd	Eosinophilic Asthma Patients	12/27	12/27
NCT05042401: A Trial of SHR-1703 in Asthma	Active, not recruiting	1	23	RoW	SHR-1703, placebo	Jiangsu HengRui Medicine Co., Ltd.	Asthma	06/23	06/23